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Abstract
Circadian rhythm abnormalities in bipolar disorder (BD) have led to a search for genetic abnormalities in circadian ‘‘clock
genes’’ associated with BD. However, no significant clock gene findings have emerged from genome-wide association
studies (GWAS). At least three factors could account for this discrepancy: complex traits are polygenic, the organization of
the clock is more complex than previously recognized, and/or genetic risk for BD may be shared across multiple illnesses. To
investigate these issues, we considered the clock gene network at three levels: essential ‘‘core’’ clock genes, upstream
circadian clock modulators, and downstream clock controlled genes. Using relaxed thresholds for GWAS statistical
significance, we determined the rates of clock vs. control genetic associations with BD, and four additional illnesses that
share clinical features and/or genetic risk with BD (major depression, schizophrenia, attention deficit/hyperactivity). Then we
compared the results to a set of lithium-responsive genes. Associations with BD-spectrum illnesses and lithium-
responsiveness were both enriched among core clock genes but not among upstream clock modulators. Associations with
BD-spectrum illnesses and lithium-responsiveness were also enriched among pervasively rhythmic clock-controlled genes
but not among genes that were less pervasively rhythmic or non-rhythmic. Our analysis reveals previously unrecognized
associations between clock genes and BD-spectrum illnesses, partly reconciling previously discordant results from past
GWAS and candidate gene studies.
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Introduction
Bipolar disorder (BD) is a serious and life-threatening mental
illness that affects 1–2% of the population. Twin and family studies
have found that the heritability of BD is up to 0.85, suggesting a
strong genetic liability [1]. But despite considerable effort, the
precise genetic factors that predispose to BD remain unknown.
Based upon clinical observations that patients with BD often
exhibit evening chronotype, disturbances in periodic daily
activities (e.g. decreased need for sleep, insomnia or hypersomnia,
disturbed appetite, and disrupted daily activity patterns), and that
mood episodes are affected by light and follow seasonal patterns, a
circadian rhythm hypothesis of BD and depression has been
developed [2]. This hypothesis has been supported by the
development of a mouse model of BD in which a mutation in
Clock, a core component of the cellular circadian clock, causes
lithium-sensitive, mania-like behavioral abnormalities [3–4].
Moreover, the mood-stabilizing drug lithium, a mainstay of
treatment for BD, also alters clock gene expression [5], and delays
circadian rhythms in rodents, monkeys, and humans [6–9].
Glycogen synthase kinase 3b (GSK3b) is inhibited by lithium
[10], and has been implicated in both lithium’s effect on circadian
rhythms [11,12], and its therapeutic action in BD [13].
While it is clear that BD is strongly influenced by genetic risk,
and circadian rhythm abnormalities are features of the illness, the
genes regulating circadian rhythms (‘‘clock genes’’) have yet to be
established as an important genetic substrate. On the one hand,
candidate clock gene studies of BD have identified a number of
variants associated with mood-related phenotypes [14–20]. On the
other hand, large scale genome wide association studies (GWAS)
including three recent meta-analyses [21–23], have not identified
clock genes as BD associated.
In addition to technical factors (e.g. low density of GWAS
markers in candidate genes), at least three fundamental issues
could explain the discrepancy in clock gene findings between
candidate gene studies and GWAS. First, complex traits are likely
to be polygenic. Therefore, individual genetic variants may
contribute small effects and/or be weakly associated with the
phenotype. For example, a recent GWAS meta-analysis of height
identified hundreds of strongly associated polymorphisms that
collectively accounted for only a small fraction of the total
phenotypic variance [24], suggesting that a large number of
weakly associated variants are contributing meaningfully. Of
interest, the height-associated genetic loci were non-randomly
distributed, showing enrichment in pathways previously implicated
in disorders of stature. Therefore BD, like height, may also be
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fail to reach the stringent threshold for genome wide significance
[25]. If so, biological pathways may provide helpful structures into
which risk-associated variants can be organized. Earlier efforts
have already shown some promise in this regard [26], including
some implicating clock genes through the convergence of multiple
sources of data [27].
A second explanation for the failure to associate clock genes
with BD in GWAS may be that the organization of the molecular
clock is more complex than previously recognized. While the
‘‘core’’ circadian clock is thought to consist of ,18 well described
genes [28], a recent genome-wide survey identified 343 genes that
modulate circadian rhythms when attenuated using siRNA
knockdown [29], suggesting that regulation of the circadian clock
is governed by a more extended set of genes than previously
appreciated. Moreover, downstream of the core clock, thousands
of clock controlled genes (CCGs) oscillate rhythmically in at least
some tissues [30]. Therefore, circadian rhythms in specific
behaviors and physiological processes are likely to be governed
not only directly by the core clock, but also indirectly by hundreds
of additional genes. It is possible, then, that groups of clock genes
or important effector mechanisms of the clock are indeed relevant
to BD, and have been collectively implicated by GWAS, but
simply not recognized.
A third explanation is that risk for BD conferred by clock genes
is distributed across multiple disorders, implying that clock genes
may be shared susceptibility genes for multiple illnesses. For
example, attention deficit hyperactivity disorder (ADHD) has been
associated with evening chronotype, sleep abnormalities and
delayed melatonin onset [31]; whereas schizophrenia (SCH) has
also been associated with abnormal melatonin rhythms and sleep,
as well as variability in daily rhythms [32,33]. Supporting this
hypothesis, candidate studies have broadened the list of psychiatric
illnesses with clock gene associations to include ADHD, major
depressive disorder (MDD) and SCH [19,34,35]. Importantly,
clock genes have been reported to regulate brain function more
broadly than initially recognized, including the motivation and
reward circuits of the midbrain dopamine system [3,4] and
neurogenesis in the hippocampus [36]. If so, clock gene variants
may predispose affected individuals to psychiatric illnesses through
multiple processes, not just by regulating sleep/wake cycles. The
implication of this hypothesis is that the risk for psychiatric illness
conferred by clock genes does not fit into existing illness categories,
and that illness associations with clock gene variants may be more
robust using a broader psychiatric phenotype.
To explore these three possibilities, we conducted a quantitative
bioinformatic survey of GWAS results that employed an online
repository of genetic data, allowing us to examine multiple GWAS
data sets for various psychiatric phenotypes simultaneously. Using
this approach, we examined the associations of clock genes with
BD and three additional psychiatric conditions for which there is
substantial evidence of shared clinical features, genetic overlap
and/or enrichment in families of affected BD probands: MDD,
SCH and ADHD [24,37–42]. Since circadian rhythm abnormal-
ities are best described in BD, we refer to this group of disorders as
the ‘‘BD spectrum’’ of illnesses in order to establish an operational
definition, but acknowledge the arbitrariness and limitations of this
BD-centered scheme. We also surveyed genes whose expression is
reportedly lithium-sensitive in mouse brain [5]. Clock genes were
examined at three separate levels: first, 18 ‘‘core clock’’ genes for
which an extensive literature supports a critical function in
maintaining circadian rhythms; second, an extended set of 342
clock modulator genes that regulate rhythm period and amplitude,
but are not involved in the central circadian oscillator; and third,
clock outputs, also called clock controlled genes (Figure 1). We
found that among the core clock genes there is a statistical over-
representation of association with BD-spectrum illnesses in GWAS
and lithium sensitive genes. CCGs that were rhythmic in multiple
tissues were more likely than weakly rhythmic or non-rhythmic
genes to show associations with BD-spectrum illnesses and/or to
be lithium-sensitive. In contrast, clock modulator genes were
illness associated and lithium responsive only at chance rates.
Methods
Psychiatric GWA study repository
GWAS data were identified using the Sullivan Laboratory
Evidence Project (SLEP), a searchable online repository of
,43,000 genetic association entries that integrates genetic
information on psychiatric illnesses from disparate sources [43,
https://slep.unc.edu/evidence, last accessed January, 2011]. All
searches were conducted by gene name. When performed in this
way, SLEP search results provide a list of SNPs in the vicinity of a
gene of interest, reporting any GWAS evidence of association with
selected disorders: BD, MDD, SCH, and ADHD. In some cases,
the same SNP may be associated with multiple illnesses. Using this
approach, the results of 14 GWAS experiments were queried
(Table S1). Results from these searches provided: 1) the study from
which the data originate, 2) any associated genetic marker(s), 3) the
p-value for the association, and 4) the size of the gene relative to
the genome average. Only p-values ,10
23 are reported by SLEP,
and we accepted this value as our threshold for association. While
this p-value is not stringent enough to test for genome-wide
significance (commonly accepted as p,10
28), it may still be
pertinent in identifying weakly associated genetic variants that may
collectively contribute to illness phenotypes. Candidate gene
coverage in GWAS platforms varies considerably. We included
in our analysis 100 kb at either end of each gene in order to ensure
capture of the majority of cis regulatory SNPs [44,45]. While
inclusion of this window could result in more false positive
associations, this source of error is the same for test and control
genes, negating its contribution to spurious association rates.
Figure 1. Organization of the extended clock network. The core
clock oscillator is a set of ,18 genes that encode for transcriptional
regulators (middle). These proteins are organized in complex feedback
loops with positive (green) and negative (red) limbs that generate the
,24 hr rhythms in gene expression responsible for maintaining
circadian rhythms. Upstream clock modulators influence the period
and/or amplitude of rhythms by altering protein stability, cellular
distribution, or phosphorylation of proteins within the core clock (top).
Core clock transcriptional regulators generate expression rhythms in
numerous downstream clock controlled genes that are not the ‘‘gears
of the clock’’ involved in generating rhythms, but may be important
effectors or ‘‘hands of the clock’’ (bottom).
doi:10.1371/journal.pone.0032091.g001
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Eighteen core clock genes were individually selected based on
their well-established roles in regulating circadian rhythms in
genetic mouse models and/or human sleep disorders. These
include: CRY1/2, PER1/2/3, NR1D1/2, RORA/B/C, DEC1/2,
CSNK1D/E, ARNTL1/2, CLOCK and NPAS2 [28].
Clock modulators
Clock modulators were defined as the 343 genes affecting
circadian period or amplitude in a high throughput siRNA screen
[29]. In these 343 cases, siRNA knockdown of the target gene led
to a change of .3 standard deviations in period (longer/shorter)
or a significant increase in amplitude, as determined by
longitudinal (96 hr) measurement of circadian rhythms of gene
expression using a Bmal::dLuc reporter gene stably expressed in a
human osteosarcoma cell line. In most cases, gene names used for
SLEP searches were identical to those used previously [29]. In
some cases (40 genes, Table S2), an alias used in the initial report
was matched manually to the equivalent gene name recognized by
SLEP. With this adjustment, all 343 genes were successfully
queried in SLEP. Among these 343 clock modulators was one core
clock gene (CRY2). This gene was therefore excluded, leaving 342
clock modulator genes used in all subsequent analyses.
Clock controlled genes
Clock controlled genes were selected from a meta-analysis of
microarray expression studies identifying 9995 mouse genes that
oscillate in at least one of 14 tissues [30]. Among this set, 148 were
defined as pervasively rhythmic clock controlled genes (PRCCGs,
rhythmic in .6 tissues). This threshold was selected in order
to enrich for genes that show widespread rhythmicity, while
maintaining adequate sample size. Of the PRCCGs, 10 were
previously identified as core clock genes and two others had no
human orthologs. After excluding these, the remaining 136
PRCCGs were used in subsequent analyses (Table S2). Weakly
rhythmic clock controlled genes (WRCCGs) were defined as one
of the 4627 genes that were previously reported to be rhythmic in
only one tissue [30]. By comparing the complete list of all
rhythmic genes to the list of 8638 genes used for random gene
selection, it was also possible to identify 4193 genes lacking
evidence for rhythmic expression in any tissue (non-rhythmic
genes). For the latter two groups, 450 genes (,10%) from each set
were randomly sampled for analysis in SLEP (Table S2).
Lithium responsive genes
Genes whose expression in mouse brain is altered by lithium
administration have been identified previously using expression
microarrays [5]. The full microarray data set was kindly provided
in its entirety by the authors. All statistical determinations of
lithium responsiveness, including false discovery (FDR) correc-
tions, were conducted by the authors of the original study. SLEP
accepts mouse gene entries as the basis for a search, automatically
retrieving the corresponding human homolog in the majority of
cases.
Random control genes
Random control gene lists were generated from the 8638 genes
present on the Affymetrix Genome Focus microarray with
inclusion on the chip determined by the manufacturer. Gene lists
were randomly generated with using a publicly available random
list generator (http://www.random.org/lists last accessed January
2011). New random gene sets for each comparison were
subsequently made for each comparison with replacement such
that gene overlap could occur in some cases by chance.
Statistical analysis
The rate of chance genome-wide association for a gene set in
the SLEP database was determined empirically using a series of
randomly generated gene sets (Figure 2A, B). For core clock genes,
sets of 20 randomly selected genes were submitted to SLEP using
the same parameters employed for the core clock genes. Random
Figure 2. The method for clock gene and random gene analysis
is summarized for three test sets. The rate of association in SLEP
was determined for sets of randomly selected genes that contained
gene numbers similar to A) core clock genes and B) clock modulator
genes. C) Pervasively rhythmic (PRCCGs), weakly rhythmic (WRCCGs)
and non-rhythmic genes were directly compared. Of 9950 clock
controlled genes, 5187 were rhythmic in 2–5 tissues. Genes of
intermediate rhythmicity were not examined.
doi:10.1371/journal.pone.0032091.g002
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number of genes with aliases that did not match the gene name in
SLEP. In these cases, genes were excluded from consideration and
the association rate was corrected to count only valid searches. For
the core clock genes, 50 replications of this process were
performed, yielding a total of 948 valid gene searches. For the
clock modulator genes, sets of 350 genes were submitted using the
same SLEP search parameters. Because the association rate of
clock modulators failed to differentiate from the controls, only 5
replications were performed for this gene set. From these base
rates, the rate of positive associations for both core clock and
modulator genes was compared against the chance rate of the
respective control sets. For clock controlled genes, the rates of
association between pervasively rhythmic, weakly rhythmic, and
non-rhythmic genes were compared directly using methods similar
to those described above (Figure 2C). In all cases, a chi-square test
was used to test the difference in association rates between clock
genes and randomly selected genes, where rate is defined as
(associations p,10
23/number of genes in list). Odds ratio (OR)
values were calculated from the chi square tests. Because only a
single hypothesis was considered for each gene set (i.e. the rate of
associations in clock genes vs. control genes), no correction for
multiple comparisons was required.
Gene matching
Where indicated, random control genes were matched to clock
genes based on relative size. To do so, random genes were run
through SLEP without replacement and matched to a clock gene
of corresponding size within 62% of genomic percentile average.
The presence or absence of an illness association was then
recorded for each control gene. The process was repeated until ten
matches per clock gene were made. Subsequent matches beyond
those required and unmatched genes were discarded. A power
analysis indicated that 10 matches per gene provided .90%
power to determine a difference in association rate between core
clock genes and controls.
SNP position and haplotype analysis
Where indicated, detailed positional information for SNPs was
obtained using the UCSC genome browser (http://genome.ucsc.
edu, March 2006 Assembly), and gene boundaries were defined by
the open reading frame posted therein. Haplotype structure was
determined using the HapMap II CEU genotype data version 3.2,
analyzed using Haploview version 4.2.
Results
Core clock gene associations
Among the core clock genes, ARNTL, DEC1, and RORB showed
evidence of association with BD (p,10
23, Table 1). Interestingly,
DEC1 was associated with BD at two distinct markers in
independent studies. When MDD, SCH, and ADHD were
considered, an additional six core clock genes (ARNTL2, NPAS2,
NR1D2, PER1, RORA, RORC) were illness-associated, as well as
two additional DEC1 SNPs associated with MDD and SCH. In
total, 9 of the 18 core clock genes (50%) had evidence for genetic
association with at least one of the selected psychiatric conditions.
Some genes were associated with multiple disorders, so a total of
13 clock gene SNP associations were found. The chance
association rate in SLEP for a control set of randomly selected
genes was empirically determined to be 3.5 variants per 18 genes
(19.5%). The number of chance associations was normally
distributed (range: 0–7), and in no case did this number equal or
exceed the 9 genes or 13 disorder associations identified using the
core clock gene set. Conservatively estimated (i.e. counting an
identified gene only once, and not including multiple illness
associations), the rate of 50% of core clock genes implicated in BD-
related psychiatric illnesses represents a significant enrichment
compared to the randomly generated sets [x
2(1)=10.23, OR 4.12,
p,0.0015].
Relationship of associated SNPs to core clock genes
The genomic position and haplotype structure of each of the 13
variants identified was then examined in detail to confirm
association with a known clock gene. Eight were located in introns
of the corresponding clock gene. Two were in probable promoter
regions of the clock gene. The remaining three SNPs (those near
PER1, NR1D2, and RORC), were located farther from the
corresponding clock gene in regions where other genes were likely
to be affected (Table 2). In the case of NR1D2, the variant
rs2001209 was located within a large haplotype block encompass-
ing several genes, and so while rs2001209 lies outside the clock
gene, it may tag a haplotype relevant to NR1D2. Therefore, the
majority of core clock SNPs identified (.10/13) were confirmed to
be located within clock genes. For a smaller number of genes (2–3),
based on proximity and linkage relationships, we could not rule
out a relationship with non-clock genes.
Core clock gene size
Gene size may also affect the chance of a spurious genetic
association: large genes contain more variants, and thus potentially
more false positive associations. Using the SLEP results, we
examined the average size of core clock genes relative to the
genome average. Core clock genes were larger on average, in the
Table 1. Core clock genes.
Core Clock
Gene Disorder
GWAS p-value
(best)
Li FDR
p-value
ARNTL BD 4.39E-04
ARNTL2 ADHD 6.15E-04
CLOCK
CSNK1D
CSNK1E
CRY1 9.80E-05
CRY2 0.24
DEC1 BD*+MDD+SCH 1.80E-04 0.09
DEC2
NPAS2 ADHD 6.10E-04
NR1D1 0.01
NR1D2 SCH 8.37E-04
PER1 SCH 8.71E-05 0.10
PER2 0.04
PER3 0.30
RORA SCH+ADHD 5.62E-05 0.23
RORB BD 8.99E-04 0.18
RORC SCH 3.90E-04
Data shown include 1) Any associations to BD and/or BD-spectrum illnesses as
determined by SLEP search (Left) 2) The best GWA p-value for a proximal SNP
obtained from SLEP (Middle) 3) A FDR corrected p-value for any gene that was
determined to be nominally lithium-responsive (Right). Bold indicates
significance after FDR correction.
doi:10.1371/journal.pone.0032091.t001
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th percentile of all genes (SD=23.7). Among core clock genes
that were positively associated with a psychiatric disease
(compared to those that were not associated), there were more
large genes (.85
th percentile), and average size tended to be
greater (78
th vs. 60
th percentile), but the overall distribution of
associated and non-associated genes was not significantly dif-
ferent. In order to more carefully control for gene size, we
repeated our analysis comparing the association rate of the 18
core clock genes to a set of 180 control genes matched to the core
clock test set. The chance association rate of the size-matched
control genes was 21.6% (39/180 genes), slightly higher than
randomly selected genes, but significantly lower than the 50%
association rate for core clock genes [x
2(1)=7.15, OR=3.61,
p,0.01], suggesting that gene size alone is not responsible for the
observed enrichment.
GWAS platform and core clock genes
Positive associations for core clock genes were derived from 9 of
the 14 eligible studies queried by SLEP, using four distinct
platforms (Table S1). This speaks against a platform-specific
artifact accounting for our observed results. The SNP density of
core clock gene coverage was examined in detail for two of these
platforms using annotation on the UCSC genome browser. SNP
density among core clock genes was found to be 9.2 kb6SNP
21
for Affymetrix 500 K and 5.7 kb6SNP
21 for the Illumina
HapMap550, compared to genome wide averages of 6.0 kb and
5.5 kb6SNP
21 respectively, speaking against an overrepresenta-
tion of core clock findings due to SNP selection artifact. Positively
associated core clock genes were not more densely covered than
genes without association [t(16)=1.62, p=0.12].
Clock modulator gene associations
Among the 342 clock modulator genes, 21 were associated with
BD by GWA. Among these, ATF6 and CCT5 were also associated
with SCH in an independent study. When the psychiatric
phenotype was extended to ADHD, MDD, and SCH, an
additional 30 clock modulator genes were implicated by GWA,
including FHIT, which was independently associated with both
ADHD and SCH. Combined, a total of 51 of the 342 clock
modulator genes (15%) were associated with at least one BD-
spectrum illness (Table 3).
After excluding invalid searches, the chance association rate for
a similarly sized set of random genes ranged from 42 to 68 per 350
(mean 57.2610), or 17.3% (286/1653 tests). Therefore, the
association rate of clock modulator genes was not significantly
different from the results expected by chance (x
2(1)=1.20, OR
0.83, p=0.27).
Clock modulator gene size
Gene size was also examined for the clock modulator genes.
Among associated genes, genomic length was in the 57
th
percentile, whereas among those without GWA associations,
genomic length was in the 50
th percentile. The size distribution
between the two groups was not significantly different (t=1.649
df=342, p=0.10).
Clock controlled gene associations
PRCCGs, WRCCGs, and non-rhythmic genes were assessed
separately for GWA evidence in SLEP. WRCCGs and non-
rhythmic genes had a similar number of positive associations in
SLEP (75/450 and 79/450 for a rate of 16.6% and 17.5%
respectively, p=0.79, NS). In contrast, PRCCGs had a positive
association rate of 25% (34/136, Table 4), reflecting a significant
enrichment compared to WRCCGs [x
2(1)=4.79, OR=1.76,
p,0.03], and a trend towards enrichment when compared to non-
rhythmic genes [x
2(1)=3.72, OR 1.57, p=0.05]. Since non-
rhythmic genes and WRCCGs did not differ, they were pooled for
comparison against PRCCGs, and the enrichment remained
significant [x
2(1)=5.62, OR 1.67, p,0.02]. Of 34 genes, 11 were
BD associations and the remaining were distributed among
ADHD, MDD, and SCH. We also examined whether rhythmic
expression in the brain favored illness association among the 136
PRCCGs. PRCCGs that were rhythmically expressed in the SCN,
frontal cortex, or whole brain [30] were no more likely to be
illness-associated than those that were not rhythmic in the brain
(SLEP association rates 24.7% and 25.7% respectively).
Overlap between clock genes, illness-associated genes,
and lithium-responsive genes
Lithium affects circadian rhythms as well as the course of BD.
By determining the overlap between clock genes, genes associated
Table 2. SNPs with psychiatric illness associations and their location relative to the most proximal clock gene.
Gene Illness Association SNP Position Relative to Gene
PER1 SCZ rs3027232 Coding region of adjacent gene ALOXE3
NR1D2 SCZ rs2001209 High density gene area ,20 kb from NR1D2, intronic in adjacent gene RPL15
RORA ADHD
SCZ
rs922781
rs1351546
intronic in RORA
intronic in RORA
RORB BD rs10869435 intronic in RORB
RORC SCZ rs868866 intronic in TDRKH ,20 kb downstream from RORC
DEC1 MDD
BD
SCZ
BD
4 SNPs
rs1537720
rs11794627
rs10982664
Intronic DEC1
DEC1 promoter, enriched chromatin
Intronic DEC1
Intronic DEC1
NPAS2 ADHD rs11674199 Intronic NPAS2
ARNTL BD rs747601 ,20 kb upstream promoter region
ARNTL2 ADHD rs11049004 Intronic in ARNTL2
The SNPs proximal to PER1 and RORC were determined to lie outside of these genes. The SNP proximal to NR1D2 was indeterminate. The remaining SNPs were
determined to be located with the corresponding clock gene.
doi:10.1371/journal.pone.0032091.t002
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number of clock genes relevant to both BD and lithium response
may be identifiable. Therefore, clock genes (core, modulators, and
CCGs) and illness-associated genes were cross-referenced against a
set of genes whose expression in the mouse brain is altered by
lithium exposure [5] in order to find genes present in all three sets.
It was expected that clock genes would be enriched in the
overlapping sets relative to randomly selected genes.
Random control data sets revealed a chance three-way overlap
rate of 58/1653 (3.5%). Eight of the 18 core clock genes (44%)
were reported as nominally lithium-responsive previously [5], and
in our three-way overlap analysis, four of the 18 (22%) core clock
genes (DEC1, PER1, RORA, RORB) were both nominally lithium-
responsive and associated with psychiatric illness by a GWA study
in SLEP (Figure 3A, Table 1). However, none remained after
employing the FDR correction for determining lithium respon-
sivity [5]. Among the 342 clock modulator genes, 57 (16%, Table
S3) were found to be nominally lithium-responsive, but only ten
of these (2.9%; BAI3, BLNK, EMP2, FBXL3, FBXO16, FBXW11,
FHIT, MAPK8, PTK2,a n dSH3GL2) were both lithium-respon-
sive and associated with psychiatric illness (Figure 3B, Table 2).
Of these genes, BAI3 and EMP2 were previously reported [5] to
be lithium-responsive after FDR correction, with MAPK8
narrowly missing the significance threshold with an FDR-
corrected p,0.06. These data suggest that the core clock is
significantly enriched in genes that are both illness-associated and
lithium-responsive (22% vs. 3.5%, x
2(1)=17.45 p,0.0001, OR
7.86), whereas clock modulators are not (p=0.87). Among
PRCCGs, 71/136 (52.2%) were nominally lithium-responsive,
compared to only 89/450 (19.7%) and 54/450 (12%) for the
randomly selected WRCCGs and non-rhythmic gene sets,
respectively (Table S3), a significant enrichment among PRCCGs
[x
2(2)=103.4, p,0.0001]. Examining the three way overlap
between clock controlled genes, illness association, and lithium-
responsiveness, PRCCGs had a three way overlap rate of 20/136
(14.7%) compared to only 15/450 (3.3%) and 9/450 (1.9%)
respectively for WRCCGs and non-rhythmic genes, a significant
difference between PRCCGs and the two other groups
[Figure 3C, x
2(1)=24.1 OR 5.0 and x
2(1)=35.84 OR=8.5,
p,0.0001 in both cases). A summary of overlap results after FDR
correction is shown in Table 5.
Discussion
Our findings support the hypothesis that variation within clock
genes contributes to BD and related illnesses like ADHD, MDD,
and SCH that share genetic and/or clinical features with BD.
While none of the individual clock genes examined has been
Table 3. BD-spectrum associated clock modulator genes.
Clock
Modulator
Gene Disorder
GWAS p-value
(best) Li FDR p-value
ANKLE1 SCH 3.62E-04
ATF6 BD+SCH 3.75E-04
B4GALT2 SCH 1.58E-04
BAI3 BD 2.91E-04 0.02
BLNK BD 8.27E-04 0.17
BOLA3 MDD 2.27E-04
BRCA2 BD 2.83E-04
C16orf82 SCH 5.46E-04
CCT5 BD+SCH 1.46E-04
CMTM7 BD 5.49E-05
EMP2 SCH 6.38E-04 9.80E-05
EMR2 MDD 2.56E-05
EPAS1 SCH 6.58E-04
FBXL3 SCH 1.53E-04 0.26
FBXO16 SCH 7.72E-04 0.15
FBXW11 BD 7.87E-04 0.08
FHIT ADHD+SCH 3.71E-04 0.19
FZD10 BD 1.76E-04
GPR45 BD 7.03E-04
HAS3 SCH 4.30E-04
IFNK BD 1.19E-04
JAZF1 BD 8.84E-04
KIAA1797 MDD 5.96E-04
LHX1 ADHD 1.79E-04
LSM7 MDD 3.77E-04
LYG SCH 1.66E-04
MAPK8 BD 4.43E-05 0.06
MED30 BD 9.12E-05
METTL11B BD 3.66E-04
MPN2 BD 7.81E-05
NHP2 SCH 8.38E-04
OPN5 SCH 6.47E-05
OXNAD1 ADHD 7.71E-04
POLR3F SCH 9.16E-05
PPM1B MDD 8.93E-04
PTK2 BD 4.41E-04 0.25
PWP2 SCH 2.43E-04
RAB20 BD 5.86E-04
RCC2 BD 7.05E-04
RCVRN SCH 8.62E-04
RETN MDD 8.86E-04
SCARA3 SCH 8.11E-04
SELO SCH 8.11E-04
SH3GL2 BD 4.49E-04 0.31
SPAG4L MDD 9.56E-04
SYCP2 MDD 7.45E-05
tAKR MDD 4.35E-04
TBC1D9 BD 3.14E-04
Clock
Modulator
Gene Disorder
GWAS p-value
(best) Li FDR p-value
TUBA1B BD 2.38E-04
UNC45B SCH 1.46E-04
WDR86 MDD 1.35E-04
Data shown include: 1) any gene associations with BD or BD-related illnesses as
determined by SLEP search (left), 2) the best GWA p-value for a proximal SNP
obtained from SLEP (middle), and 3) an FDR-corrected p-value for any gene that
was determined to be nominally lithium-responsive (right). Bold indicates
significance after FDR correction.
doi:10.1371/journal.pone.0032091.t003
Table 3. Cont.
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BD spectrum illnesses at a rate higher than would be expected by
chance, i.e. there are more illness-associated genes among the 18
core clock genes than among similarly sized control sets of
randomly selected genes. This enrichment is limited to the core
clock genes and their most pervasively rhythmic biological outputs,
the PRCCGs, and does not extend to either the modulator genes
that have been shown to alter clock period and amplitude [29], or
to less pervasively rhythmic genes (WRCCGs). Taking lithium-
responsiveness into account, we find a similar pattern of results:
genes that are both illness-associated and lithium-responsive are
significantly enriched among core clock genes and among
PRCCGs, but not among clock modulators or WRCCGs.
Collectively, our findings support the hypothesis that the modest
associations between BD-spectrum illnesses and single clock genes
found in GWAS represent real effects that are too weak to achieve
genome-wide significance, and that the clock gene network
represents an important point of convergence for BD and the
mechanism of action for lithium. Like another recent finding that
implicated the clock genes ARNTL and RORB in BD [27], our
results demonstrate the value of strategies that integrate disparate
sources of biological and genetic data.
The technique used in our study has limitations. The studies in
SLEP do not include GWAS data published after 2009 (Table S1),
and therefore do not utilize the most recent and presumably, most
advanced GWAS results for the disorders of interest. Among these
is a GWAS of anti-depressant response in MDD that identified
RORA among the most strongly associated alleles [46]. Many of
these newer GWAS have utilized subjects of non-European
ancestry, whereas studies included in SLEP utilized primarily
Caucasians. Therefore our searches while extensive, were not
comprehensive, and may have failed to detect some associations of
interest. Moreover, the results may not generalize to non-
Caucasians. The original GWA studies also differ in methodology.
However, in all but one study, the number of SNPs tested was
similar (435–600 thousand, Table S1), and the sample sizes of
studies yielding clock associations and those that did not were not
significantly different.
Similar caveats apply to the gene expression data. A number of
microarray expression studies have been conducted in rodent
brains, but agreement among their results is rare [13,47–49]. In
each case, there are differences in lithium administration, the brain
regions examined and the microarray platform employed that may
explain the divergence of findings. In examining the genes affected
by lithium in one of these additional studies, an examination of the
rat frontal cortex [49], no core clock genes were represented; only
BMP4, DDX3X, IKBKB and WNT2 overlapped with our list of
clock modulators, and only BHLHB2, GJA1, and PFKFB3
overlapped with our list of PRCCGs. Of these, only PFKFB3
was associated with a psychiatric illness in our SLEP search.
Therefore, the differences in gene expression implicated in BD/
lithium response may vary by experimental condition, making the
catalogue of BD/lithium-associated clock genes subject to revision
as data emerge.
A further limitation is that because our search strategy required
manual data input, the number of searches conducted to establish
empirical p-values was relatively small compared to a fully
automated approach. Therefore with more repetitions, more
precise estimates of chance association could be established.
Finally, the haplotype structure of the clock genes could bias our
results if they deviated systematically from the rest of the genome.
Indeed, certain classes of genes are predisposed towards or against
genomic rearrangement, and might be expect to harbor atypical
haplotype structures [50,51]. However, the clock genes have not
been previously implicated in this regard [50,51], and in our own
analysis, clock genes show a wide range of haplotype structures,
with estimates of mean linkage disequilibrium across the gene (D9)
that range from 0.50 to 0.99, and are inversely correlated
(r=20.46) to gene size, typical of haplotype relationships reported
elsewhere [50]. Thus, there does not appear to be a systematic bias
in clock gene propensity for re-arrangement that could adversely
affect our results.
Our findings argue against the hypothesis that GWAS have
overlooked strong (i.e. genome-wide significant) associations
between BD and previously unrecognized clock genes. However,
we did find support for the hypothesis that pathological clock gene
Table 4. Pervasively rhythmic clock-controlled genes
associated with BD-spectrum illnesses.
Clock
ControlledGene Disorder
GWAS p-value
(best)
Li FDR
p-value
ACSL1 ADHD 6.91E-04
ANP32A MDD 6.51E-04 0.25
BTF3L4 SCH 2.46E-04
CAPRIN1 BD 5.34E-05
CEBPB MDD 3.59E-04
COL4A1 SCH 5.99E-04 0.24
COL4A2 SCH 5.99E-04
COL6A1 ADHD 5.38E-04
DUSP1 BD 5.36E-04 0.18
ELOVL5 SCH 6.44E-04 0.21
FOXP1 BD+MDD+SCH 3.43E-05 0.20
GLUL MDD 9.81E-04 4.79E-03
H1F0 ADHD 1.85E-04 0.25
H3F3B SCH 9.07E-05 0.02
HERPUD1 MDD 4.11E-04 0.02
HIST1H1C SCH 3.71E-04 2.90E-03
HIST1H2BC SCH 3.49E-04 0.21
HMGB3 BD 4.05E-04
MAPRE1 MDD+SCH 1.12E-04 0.04
MCL1 ADHD 8.23E-04 0.09
NAMPT BD+MDD 6.46E-04
NEDD4L ADHD 9.34E-05 0.17
PDIA6 ADHD 7.63E-04
PFKFB3 BD+MDD 7.67E-05 0.15
PSMD11 MDD+SCH 4.28E-04 0.02
SASH1 MDD 8.16E-04 0.08
SFRS5 BD 9.66E-04 0.03
SFRS6 ADHD+SCH 1.20E-04
SLC4A4 BD 2.13E-05 0.07
TIMP3 BD 7.16E-05 0.02
TUBA1B BD 2.38E-04
UBC MDD 1.34E-04
ZNF706 BD 3.72E-05
Data shown include 1) any gene associations with BD or BD-related illnesses as
determined by SLEP search (left), 2) the best GWA p-value for a proximal SNP
obtained from SLEP (middle), 3) an FDR-corrected p-value for any gene that was
determined to be nominally lithium-responsive (right). Bold indicates
significance after FDR correction.
doi:10.1371/journal.pone.0032091.t004
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suggest that within the BD-spectrum, clock gene variation is not
enriched in any particular disorder, although methodological
differences between studies and differences in the number of
studies of each illness make these comparisons tentative. In this
context, it remains an important issue for future research to further
define the rhythm abnormalities in BD-spectrum disorders, more
carefully identifying both the unique phenotypes and areas of
overlap shared across the illness, then connecting these to specific
genetic and neurobiological substrates.
Based on our findings, we conclude that the major influence of
the clock on BD spectrum illnesses originates within the core clock
and its downstream effector systems, rather than in upstream clock
modulators. This suggests that previously noted associations
between circadian rhythms and mood disorders not likely to be
explained by a common process upstream of both the circadian
clock and mood regulatory mechanisms, but rather argues for a
more fundamental connection between the clock and mood. The
apparent lack of brain specific rhythms among illness-associated
PRCCGs is somewhat surprising and points to the possibility of
indirect roles in illness progression, perhaps involving immune,
endocrine, and/or developmental processes that are not primarily
regulated in the brain. Alternatively, this lack of brain specificity
would also be expected if the clock’s influence on mood involves
ubiquitous intracellular signaling pathways found in non-neuronal
cells as well as in neurons.
The criteria employed for PRCCGs selection precludes the
detailed examination of several CCGs with expression patterns
restricted to anatomically discrete regions. Among these are many
genes of particular interest to the BD-spectrum, including those
involved in monoamine and melatonin synthesis such as TPH1
and AANAT, both of which are expressed rhythmically in a tissue
specific manner [30]. Of note, analysis of TPH1 in SLEP revealed
a weak association to BD (not shown). It is also worth noting that
several PRCCGs not found to be illness-associated in SLEP have
nevertheless been implicated in BD and/or related phenotypes by
other studies. Examples include MARCKS [52], BCL2 [53], FKBP5
[54], and CDKN1A [55], which have been implicated in lithium’s
mechanism of action, apoptosis, glucocorticoid signaling, and
neurogenesis respectively. In this context, it is tempting to
speculate that the clock may connect several disparate biological
processes thought to contribute to BD and the related spectrum
illnesses.
While the clock modulators were not significantly over-
represented among genes associated with psychiatric disorders,
the genes highlighted by this work may nonetheless be worthy of
future study. Of the ten clock modulator genes that are both
illness-associated and lithium-responsive, most are expressed in the
mouse brain (Allen Brain Atlas), and a majority of these are highly
expressed in the hippocampus, a structure implicated in both
mood disorders and lithium response. Also noteworthy is that
SH3GL2 and FHIT, two of the clock modulator genes that are
Figure 3. Overlap among clock genes, genes associated with BD spectrum illnesses by GWAS, and lithium-responsive genes. For
each set of genes, the % associated with BD spectrum illnesses by GWAS (blue), the % found to be lithium-responsive (red), and the overlap between
these (purple) is shown for 18 core clock genes (A), 342 clock modulator genes (C) and 136 pervasively rhythmic clock controlled genes (CCGs) (E)
compared to their respective randomly selected controls (B and D), CCGs that are less pervasively rhythmic (F), and genes with no evidence for
rhythmicity (G). Gray indicates % of genes with no relationship to either BD or lithium response.
doi:10.1371/journal.pone.0032091.g003
Table 5. Summary of the extended clock gene set included in
the overlap between BD-spectrum and lithium induction after
FDR correction.
Illness Core Clock Clock Modulators Clock Controlled
ADHD None None None
BD None BAI3 SFRS5
TIMP3
MDD None None GLUL
HERPUD1
MAPRE1
PSMD11
SCH None EMP2 H3F3B
MAPRE1
PSMD11
doi:10.1371/journal.pone.0032091.t005
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two chromosomal areas (9p22.2 and 3p14) associated with
comorbid BD and alcoholism [56]. Thus, it would be premature
to dismiss upstream clock modulator genes as contributors to
human psychopathology.
Taken together, our findings encourage the continued study of
clock gene variants and their role in BD, lithium response, and
related mental illnesses. However, our work also raises the
problem of focusing too narrowly on individual genetic variants
that, while functional, may be have relatively weak effects in
isolation. Our work suggests that biological characterization of
genetic variants of interest may be best accomplished using
pathway based approaches that can assess overall function of a
system, considering simultaneously multiple inputs that may
impact upon it. In this respect, the circadian clock is well suited
for further study, as molecular alterations in clock genes cause
measurable changes in gene network function in single cells (e.g.
gene expression rhythms), consequences for physiological process
measured in tissues (e.g. endocrine rhythms), and consequences for
behaviors that can be measured in whole animals or human
patients (e.g. sleep/wake activity). Using this multi-level approach,
genetic associations may reveal important nodes in the system that
can be better characterized in functional studies.
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